Correlation Between Mineralys Therapeutics, and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Mineralys Therapeutics, and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Acrivon Therapeutics,.
Diversification Opportunities for Mineralys Therapeutics, and Acrivon Therapeutics,
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Mineralys and Acrivon is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Acrivon Therapeutics,
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 0.93 times more return on investment than Acrivon Therapeutics,. However, Mineralys Therapeutics, Common is 1.08 times less risky than Acrivon Therapeutics,. It trades about -0.01 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.06 per unit of risk. If you would invest 1,195 in Mineralys Therapeutics, Common on November 2, 2024 and sell it today you would lose (168.00) from holding Mineralys Therapeutics, Common or give up 14.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Acrivon Therapeutics, |
Mineralys Therapeutics, and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Acrivon Therapeutics,
The main advantage of trading using opposite Mineralys Therapeutics, and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Mineralys Therapeutics, vs. Dine Brands Global | Mineralys Therapeutics, vs. El Pollo Loco | Mineralys Therapeutics, vs. Flanigans Enterprises | Mineralys Therapeutics, vs. Saia Inc |
| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |